This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Patrys Limited. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Arndt-Rene Kelter: Innovator in Antibody Development
Introduction
Arndt-Rene Kelter is a notable inventor based in Alfter, Germany. He has made significant contributions to the field of antibody development, particularly in the context of cancer treatment. With a total of 2 patents, his work focuses on innovative methods and compositions that have the potential to impact therapeutic approaches.
Latest Patents
Kelter's latest patents include groundbreaking inventions related to LM-antibodies and functional fragments. One of his notable inventions provides LM-1 antibodies, functional fragments, modified and variant forms, as well as nucleic acid and other compositions. These innovations are designed to bind to the LM-1 antigen, which is crucial for developing treatment and diagnostic methods. One method outlined in his patents involves treating metastasis of neoplasia, tumors, or cancer by administering LM-1 antibodies or functional fragments to patients in need.
Another significant patent is focused on the epitopes of an antibody known as PAT-LM1. This disclosure relates to the methods for utilizing these epitopes, further enhancing the potential applications of his research in medical science.
Career Highlights
Arndt-Rene Kelter has established himself as a key figure in the field of antibody research. His work at Patrys Limited has allowed him to explore innovative solutions for complex medical challenges. His patents reflect a commitment to advancing therapeutic options for patients suffering from cancer and other serious conditions.
Collaborations
Kelter has collaborated with esteemed colleagues, including Barbara E Power and Christopher Garth Hosking. These partnerships have contributed to the development of his innovative ideas and the successful execution of his research projects.
Conclusion
Arndt-Rene Kelter's contributions to antibody development and cancer treatment exemplify the impact of innovation in the medical field. His patents not only showcase his expertise but also hold promise for future advancements in therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile